These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 27667377)
1. Emerging Treatments for Heterozygous and Homozygous Familial Hypercholesterolemia. Baum SJ; Soffer D; Barton Duell P Rev Cardiovasc Med; 2016; 17(1-2):16-27. PubMed ID: 27667377 [TBL] [Abstract][Full Text] [Related]
2. [Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment]. Češka R; Štulc T; Votavová L; Schwarzová L; Vaclová M; Freiberger T Vnitr Lek; 2016; 62(11):887-894. PubMed ID: 28128575 [TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FHMarburg (FH p.W556R). Schaefer JR; Kurt B; Sattler A; Klaus G; Soufi M Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):2-6. PubMed ID: 22528129 [TBL] [Abstract][Full Text] [Related]
4. Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia. Bell DA; Hooper AJ; Watts GF; Burnett JR Vasc Health Risk Manag; 2012; 8():651-9. PubMed ID: 23226021 [TBL] [Abstract][Full Text] [Related]
5. New Therapeutic Approaches for Familial Hypercholesterolemia. Ajufo E; Rader DJ Annu Rev Med; 2018 Jan; 69():113-131. PubMed ID: 29414257 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of hepatic microsomal triglyceride transfer protein - a novel therapeutic option for treatment of homozygous familial hypercholesterolemia. Vuorio A; Tikkanen MJ; Kovanen PT Vasc Health Risk Manag; 2014; 10():263-70. PubMed ID: 24851052 [TBL] [Abstract][Full Text] [Related]
7. Familial hypercholesterolemia treatments: Guidelines and new therapies. Raal FJ; Hovingh GK; Catapano AL Atherosclerosis; 2018 Oct; 277():483-492. PubMed ID: 30270089 [TBL] [Abstract][Full Text] [Related]
8. Balancing Low-density Lipoprotein Cholesterol Reduction and Hepatotoxicity With Lomitapide Mesylate and Mipomersen in Patients With Homozygous Familial Hypercholesterolemia. Won JI; Zhang J; Tecson KM; McCullough PA Rev Cardiovasc Med; 2017; 18(1):21-28. PubMed ID: 28509890 [TBL] [Abstract][Full Text] [Related]
9. Mipomersen and lomitapide: Two new drugs for the treatment of homozygous familial hypercholesterolemia. Gouni-Berthold I; Berthold HK Atheroscler Suppl; 2015 May; 18():28-34. PubMed ID: 25936301 [TBL] [Abstract][Full Text] [Related]
10. Role of LDL apheresis in a case of homozygous familial hypercholesterolemia. Naveen T; Biswas A; Wig N; Soneja M; Jorwal P; Durga CS; Singla P; Chaudhary C; Baitha U Drug Discov Ther; 2019; 13(1):59-61. PubMed ID: 30880324 [TBL] [Abstract][Full Text] [Related]
12. Familial hypercholesterolemia: etiology, diagnosis and new treatment options. Gouni-Berthold I; Berthold HK Curr Pharm Des; 2014; 20(40):6220-9. PubMed ID: 24953396 [TBL] [Abstract][Full Text] [Related]
13. HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom. France M; Rees A; Datta D; Thompson G; Capps N; Ferns G; Ramaswami U; Seed M; Neely D; Cramb R; Shoulders C; Barbir M; Pottle A; Eatough R; Martin S; Bayly G; Simpson B; Halcox J; Edwards R; Main L; Payne J; Soran H; Atherosclerosis; 2016 Dec; 255():128-139. PubMed ID: 27839699 [TBL] [Abstract][Full Text] [Related]
14. Severe familial hypercholesterolaemia: current and future management. Farnier M; Bruckert E Arch Cardiovasc Dis; 2012 Dec; 105(12):656-65. PubMed ID: 23199621 [TBL] [Abstract][Full Text] [Related]
15. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. Jensen HK Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167 [TBL] [Abstract][Full Text] [Related]